SINTX Technologies Inc. of Salt Lake City has named Ryan Elmore as its new president. The appointment becomes effective on March 16.
SINTX Technologies is an advanced ceramics and biomaterials company focused on silicon nitride solutions for medical and other high-value applications, including biomedical implants, such as spinal fusion devices.
Elmore most recently served as core business director at Invibio, a division of U.K.-based Victrex. With more than 15 years of experience in advanced biomaterials and medical device commercialization, he has a track record of building go-to-market strategies, developing strategic accounts and scaling revenue through partner-driven commercialization. The company said he will be responsible for executing SINTX’s business and operational strategy as the company accelerates its evolution from a product-focused medical device manufacturer to a broader biomaterials platform company.
“Ryan is a proven commercial leader, and his appointment represents an important step as we continue to advance SINTX’s evolution into a platform company,” said Eric K. Olson, chairman and CEO of SINTX. “SINTX is uniquely positioned at the intersection of advanced ceramics, polymer composites and biomaterials. Ryan’s mandate is clear: implement a disciplined commercial execution strategy that translates our platform assets into scalable revenue opportunities.
“I am excited to join SINTX at a defining moment in its evolution,” said Elmore. “SINTX has built a differentiated platform around silicon nitride biomaterials, supported by deep materials science expertise, a strong intellectual property foundation and U.S.-based manufacturing. My focus will be to execute a commercial strategy aimed at supporting market engagement across multiple verticals. We believe these technologies have the potential to address meaningful clinical needs, and we intend to build momentum through disciplined execution, quality and service.”
Olson said Elmore will work closely with the company’s manufacturing, quality, regulatory and R&D teams to support product development, regulatory compliance and business development initiatives, including potential distribution, licensing and strategic partnership opportunities.